A seminar "Pharmacoepidemiological and pharmacoeconomic methods in practice" was held at the "Semey Medical University" from April 8 to April 19, 2019, organized by the Department of Pharmacology named after MD, Professor MN Musin, as part of the visit of Professor Natalia Cebotarenko, WHO expert, Executive director of CoRSUM – Coalition for Rational and Safe Use of Medicines.
Kazakhstan is introducing norms on the ethical promotion and rational use of medicines. On December 28, 2018, the Law of the Republic of Kazakhstan No. 211-VI “On Amendments and Additions to Certain Legislative Acts of the Republic of Kazakhstan on the Circulation of Medicinal Products and Medical Products” was adopted. According to the Minister of Health of the Republic of Kazakhstan Yelzhan Birtanov, these amendments were developed in accordance with the message of the President of the Republic of Kazakhstan to the people of Kazakhstan: "The main goals of the draft law are to ensure the economic availability, quality and safety of medicines and medical devices, rational use of medicines, improvement of the procurement planning system of medicines and medical products. "
One of the main innovations is the introduction of standards for the rational use of medicines through the development of a formulary system, as well as ethical promotion of medicines and medical devices. The amendments to the Code of Health of the People included a provision that provides for the development of a formulary system that will ensure the optimal use of effective, safe, cost-effective medicines. Kazakhstan has a 3-level Formulary system – at the level of the organization, the region and the republic. With the introduction of the new law, medical organizations will have to ensure the rational use of drugs, the training of clinical pharmacologists and clinical pharmacists, as well as regular training of health professionals in the rational use of drugs.
With the rational use of drugs, drug treatment should not only comply with clinical indications, in doses that meet the individual needs of the patient for a sufficient period of time, but also follow the principle of least economic costs.
The basis for the rational use of drugs is the introduction into practical public health of two modern areas of clinical pharmacology – pharmacoepidemiology and pharmacoeconomics. Pharmacoepidemiology is the main discipline that studies the comparative efficacy of drugs, using methods to compare the results of two or more therapeutic alternatives.
Pharmacoepidemiological studies allow to determine the spent funds for the treatment of the disease, so their results can be used for further analysis in pharmacoeconomic studies.